News | July 28, 2022
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Subscribe To Our Newsletter & Stay Updated
